Fisher Asset Management’s Moderna MRNA Stock Holding History

Fisher Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$760K	Buy	+10,854	New	+$562K	﹤0.01%	741
2024 Q4	–	Sell	-6,265	Closed	-$419K	–	998
2024 Q3	$419K	Buy	+6,265	New	+$575K	﹤0.01%	781
2024 Q1	–	Sell	-2,067	Closed	-$206K	–	1019
2023 Q4	$206K	Buy	+2,067	New	+$174K	﹤0.01%	950
2023 Q1	–	Sell	-1,638	Closed	-$294K	–	1161
2022 Q4	$294K	Buy	+1,638	New	+$268K	﹤0.01%	918
2022 Q3	–	Sell	-2,136	Closed	-$305K	–	979
2022 Q2	$305K	Sell	2,136 -64	-3%	-$9.15K	﹤0.01%	791
2022 Q1	$379K	Sell	2,200 -385	-15%	-$64.8K	﹤0.01%	777
2021 Q4	$657K	Buy	2,585 +319	+14%	+$93.3K	﹤0.01%	710
2021 Q3	$872K	Sell	2,266 -697	-24%	-$257K	﹤0.01%	642
2021 Q2	$696K	Buy	2,963 +1,371	+86%	+$245K	﹤0.01%	668
2021 Q1	$208K	Sell	1,592 -335	-17%	-$48.5K	﹤0.01%	855
2020 Q4	$201K	Buy	+1,927	New	+$195K	﹤0.01%	878

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Fisher Asset Management's MRNA Position: Q2 2026 in Review

Fisher Asset Management opened a new position in Moderna (MRNA) in Q2 2026: 10,854 shares worth $760K. The stake represents ﹤0.01% of the portfolio and ranks #741 among its holdings. This is a return to the name: Fisher Asset Management previously reported a position in MRNA as recently as Q3 2024.

Fisher Asset Management first reported a position in MRNA in Q4 2020 and has held it in 11 quarters since. The position peaked at $872K in Q3 2021. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Fisher Asset Management held 10,854 shares of Moderna worth $760K as of Q2 2026.
Moderna was a new Fisher Asset Management position in Q2 2026.
Moderna made up ﹤0.01% of Fisher Asset Management's portfolio in Q2 2026, its #741 holding.
Fisher Asset Management first reported a position in Moderna in Q4 2020 and has held it in 11 quarters since.
Fisher Asset Management's Moderna position peaked at $872K in Q3 2021.
780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.